Lexaria Bioscience Corp. SEC filings LEXX

Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.

Form Description Filed Period
10-Q Quarterly report Jul 13, 2026 May 31, 2026
10-Q Quarterly report Apr 13, 2026 Feb 28, 2026
10-Q Quarterly report Jan 13, 2026 Nov 30, 2025
10-Q Quarterly report Jul 14, 2025 May 31, 2025
10-Q Quarterly report Apr 14, 2025 Feb 28, 2025
10-Q Quarterly report Jan 10, 2025 Nov 30, 2024
10-Q Quarterly report Jul 12, 2024 May 31, 2024
10-Q Quarterly report Apr 9, 2024 Feb 29, 2024
10-Q Quarterly report Jan 12, 2024 Nov 30, 2023
10-Q Quarterly report Jul 14, 2023 May 31, 2023
10-Q Quarterly report Apr 14, 2023 Feb 28, 2023
10-Q/A Amended quarterly report Jan 18, 2023 Nov 30, 2022
10-Q Quarterly report Jan 17, 2023 Nov 30, 2022
10-Q Quarterly report Jul 14, 2022 May 31, 2022
10-Q Quarterly report Apr 11, 2022 Feb 28, 2022
10-Q Quarterly report Jan 14, 2022 Nov 30, 2021
10-Q Quarterly report Jul 15, 2021 May 31, 2021
10-Q Quarterly report Apr 14, 2021 Feb 28, 2021
10-Q Quarterly report Jan 14, 2021 Nov 30, 2020
10-Q Quarterly report Jun 29, 2020 May 31, 2020
10-Q Quarterly report Apr 3, 2020 Feb 29, 2020
10-Q Quarterly report Jan 9, 2020 Nov 30, 2019
10-Q Quarterly report Jul 8, 2019 May 31, 2019
10-Q Quarterly report Apr 15, 2019 Feb 28, 2019
10-Q Quarterly report Jan 11, 2019 Nov 30, 2018
10-Q Quarterly report Jul 13, 2018 May 31, 2018
10-Q Quarterly report Apr 12, 2018 Feb 28, 2018
10-Q Quarterly report Jan 12, 2018 Nov 30, 2017
10-Q Quarterly report Jul 14, 2017 May 31, 2017
10-Q Quarterly report Apr 14, 2017 Feb 28, 2017
10-Q Quarterly report Jan 13, 2017 Nov 30, 2016
10-Q Quarterly report Jul 13, 2016 May 31, 2016
10-Q Quarterly report Apr 13, 2016 Feb 29, 2016
10-Q Quarterly report Jan 8, 2016 Nov 30, 2015
10-Q Quarterly report Jul 14, 2015 May 31, 2015
10-Q Quarterly report Apr 14, 2015 Feb 28, 2015
10-Q Quarterly report Jan 14, 2015 Nov 30, 2014
10-Q/A Amended quarterly report Nov 14, 2014 Jul 31, 2014
10-Q Quarterly report Sep 11, 2014 Jul 31, 2014
10-Q Quarterly report Jun 12, 2014 Apr 30, 2014
10-Q Quarterly report Mar 12, 2014 Jan 31, 2014
10-Q Quarterly report Sep 10, 2013 Jul 31, 2013
10-Q Quarterly report Jun 12, 2013 Apr 30, 2013
10-Q Quarterly report Mar 13, 2013 Jan 31, 2013
10-Q Quarterly report Sep 12, 2012 Jul 31, 2012
10-Q Quarterly report Jun 7, 2012 Apr 30, 2012
10-Q Quarterly report Mar 13, 2012 Jan 31, 2012
10-Q Quarterly report Sep 14, 2011 Jul 31, 2011
10-Q Quarterly report Jun 13, 2011 Apr 30, 2011
10-Q Quarterly report Mar 15, 2011 Jan 31, 2011
10-Q Quarterly report Sep 7, 2010 Jul 31, 2010
10-Q Quarterly report Jun 1, 2010 Apr 30, 2010
10-Q Quarterly report Mar 15, 2010 Jan 31, 2010
10-Q/A Amended quarterly report Sep 3, 2009 Jul 31, 2009
10-Q Quarterly report Sep 3, 2009 Jul 31, 2009

Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LEXX (Nasdaq)
Fiscal year ends
August 31
Incorporated in
NV
Headquarters
Kelowna, British Columbia, Canada
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1348362
Former names
Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.